{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:29:02Z","timestamp":1787804942593,"version":"build-2784847793"},"reference-count":193,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100008233","name":"Shanghai Jiao Tong University Medical School","doi-asserted-by":"publisher","award":["TM201520"],"award-info":[{"award-number":["TM201520"]}],"id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671103"],"award-info":[{"award-number":["81671103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8201101090"],"award-info":[{"award-number":["8201101090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Wilson\u2019s disease (WD) is an inherited disease caused by mutations in ATP7B and is\ncharacterized by the pathological accumulation of copper in the liver and brain. Common clinical\nmanifestations of WD include a wide range of liver disease and neurological symptoms. In some\npatients, psychiatric symptoms may be the only manifestation at the time of diagnosis. The clinical\nfeatures of WD are highly variable and can mimic any disease of internal medicine. Therefore, for\nunexplained medical diseases, the possibility of WD should not be ignored. Early diagnosis and\ntreatment can improve the prognosis of WD patients and reduce disability and early death. Gene\nsequencing is becoming a valuable method to diagnose WD, and if possible, all WD patients and\ntheir siblings should be genetically sequenced. Copper chelators including D-penicillamine, trientine,\nand dimercaptosuccinic acid can significantly improve the liver injury and symptoms of WD\npatients but may have a limited effect on neurological symptoms. Zinc salts may be more appropriate\nfor the treatment of asymptomatic patients or for the maintenance treatment of symptomatic\npatients. High-quality clinical trials for the drug treatment of WD are still lacking, therefore, individualized\ntreatment options for patients are recommended. Individualized treatment can be determined\nbased on the clinical features of the WD patients, efficacy and adverse effects of the drugs,\nand the experience of the physician. Liver transplantation is the only effective method to save patients\nwith acute liver failure or with severe liver disease who fail drug treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1570159x18666200429233517","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T08:40:51Z","timestamp":1588236051000},"page":"465-485","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Management Perspective of Wilson\u2019s Disease: Early Diagnosis and Individualized Therapy"],"prefix":"10.2174","volume":"19","author":[{"given":"Xiang-Zhen","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Neurology, TongRen Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Min","family":"Yang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of the Institute of Neurology, Anhui University of Chinese Medicine, Hefei,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, TongRen Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1081\/CLT-100102421","volume":"37","author":"Barceloux D.G.","year":"1999","unstructured":"Barceloux D.G.; Copper. J Toxicol Clin Toxicol 1999,37(2),217-230","journal-title":"J Toxicol Clin Toxicol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/ng1293-344","volume":"5","author":"Tanzi R.E.","year":"1993","unstructured":"Tanzi R.E.; Petrukhin K.; Chernov I.; Pellequer J.L.; Wasco W.; Ross B.; Romano D.M.; Parano E.; Pavone L.; Brzustowicz L.M.; The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993,5(4),344-350","journal-title":"Nat Genet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0140-6736(00)02556-3","volume":"356","author":"Gu M.","year":"2000","unstructured":"Gu M.; Cooper J.M.; Butler P.; Walker A.P.; Mistry P.K.; Dooley J.S.; Schapira A.H.; Oxidative-phosphorylation defects in liver of patients with Wilson\u2019s disease. Lancet 2000,356(9228),469-474","journal-title":"Lancet"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","volume":"14","author":"Bandmann O.","year":"2015","unstructured":"Bandmann O.; Weiss K.H.; Kaler S.G.; Wilson\u2019s disease and other neurological copper disorders. Lancet Neurol 2015,14(1),103-113","journal-title":"Lancet Neurol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2174\/1570159X16666180508113025","volume":"17","author":"Wang B.","year":"2019","unstructured":"Wang B.; Wang X.P.; Does ceruloplasmin defend against neurodegenerative diseases? Curr Neuropharmacol 2019,17(6),539-549","journal-title":"Curr Neuropharmacol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.amjcard.2017.08.025","volume":"120","author":"Grandis D.J.","year":"2017","unstructured":"Grandis D.J.; Nah G.; Whitman I.R.; Vittinghoff E.; Dewland T.A.; Olgin J.E.; Marcus G.M.; Wilson\u2019s disease and cardiac myopathy. Am J Cardiol 2017,120(11),2056-2060","journal-title":"Am J Cardiol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","volume":"4","author":"Cz\u0142onkowska A.","year":"2018","unstructured":"Cz\u0142onkowska A.; Litwin T.; Dusek P.; Ferenci P.; Lutsenko S.; Medici V.; Rybakowski J.K.; Weiss K.H.; Schilsky M.L.; Wilson disease. Nat Rev Dis Primers 2018,4(1),21","journal-title":"Nat Rev Dis Primers"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00439-006-0202-5","volume":"120","author":"Ferenci P.","year":"2006","unstructured":"Ferenci P.; Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet 2006,120(2),151-159","journal-title":"Hum Genet"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0168-8278(01)00219-7","volume":"35","author":"Caca K.","year":"2001","unstructured":"Caca K.; Ferenci P.; K&#xFC;hn H.J.; Polli C.; Willgerodt H.; Kunath B.; Hermann W.; M&#xF6;ssner J.; Berr F.; High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol 2001,35(5),575-581","journal-title":"J Hepatol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/NRL.0b013e31825cf3b7","volume":"18","author":"Mihaylova V.","year":"2012","unstructured":"Mihaylova V.; Todorov T.; Jelev H.; Kotsev I.; Angelova L.; Kosseva O.; Georgiev G.; Ganeva R.; Cherninkova S.; Tankova L.; Savov A.; Tournev I.; Neurological symptoms, genotype-phenotype correlations and ethnic-specific differences in Bulgarian patients with Wilson disease. Neurologist 2012,18(4),184-189","journal-title":"Neurologist"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/hep.30280","volume":"69","author":"Ferenci P.","year":"2019","unstructured":"Ferenci P.; Stremmel W.; Cz\u0142onkowska A.; Szalay F.; Viveiros A.; St&#xE4;ttermayer A.F.; Bruha R.; Houwen R.; Pop T.L.; Stauber R.; Gschwantler M.; Pfeiffenberger J.; Yurdaydin C.; Aigner E.; Steindl-Munda P.; Dienes H.P.; Zoller H.; Weiss K.H.; Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson Disease. Hepatology 2019,69(4),1464-1476","journal-title":"Hepatology"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1086\/514864","volume":"61","author":"Shah A.B.","year":"1997","unstructured":"Shah A.B.; Chernov I.; Zhang H.T.; Ross B.M.; Das K.; Lutsenko S.; Parano E.; Pavone L.; Evgrafov O.; Ivanova-Smolenskaya I.A.; Anner&#xE9;n G.; Westermark K.; Urrutia F.H.; Penchaszadeh G.K.; Sternlieb I.; Scheinberg I.H.; Gilliam T.C.; Petrukhin K.; Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 1997,61(2),317-328","journal-title":"Am J Hum Genet"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/brain\/awt035","volume":"136","author":"Coffey A.J.","year":"2013","unstructured":"Coffey A.J.; Durkie M.; Hague S.; McLay K.; Emmerson J.; Lo C.; Klaffke S.; Joyce C.J.; Dhawan A.; Hadzic N.; Mieli-Vergani G.; Kirk R.; Elizabeth Allen K.; Nicholl D.; Wong S.; Griffiths W.; Smithson S.; Giffin N.; Taha A.; Connolly S.; Gillett G.T.; Tanner S.; Bonham J.; Sharrack B.; Palotie A.; Rattray M.; Dalton A.; Bandmann O.; A genetic study of Wilson\u2019s disease in the United Kingdom. Brain 2013,136(Pt 5),1476-1487","journal-title":"Brain"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3748\/wjg.v10.i4.590","volume":"10","author":"Liu X.Q.","year":"2004","unstructured":"Liu X.Q.; Zhang Y.F.; Liu T.T.; Hsiao K.J.; Zhang J.M.; Gu X.F.; Bao K.R.; Yu L.H.; Wang M.X.; Correlation of ATP7B genotype with phenotype in Chinese patients with Wilson disease. World J Gastroenterol 2004,10(4),590-593","journal-title":"World J Gastroenterol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"638","DOI":"10.7150\/thno.14596","volume":"6","author":"Dong Y.","year":"2016","unstructured":"Dong Y.; Ni W.; Chen W.J.; Wan B.; Zhao G.X.; Shi Z.Q.; Zhang Y.; Wang N.; Yu L.; Xu J.F.; Wu Z.Y.; Spectrum and Classification of ATP7B variants in a large cohort of chinese patients with Wilson\u2019s Disease Guides Genetic Diagnosis. Theranostics 2016,6(5),638-649","journal-title":"Theranostics"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/humu.20574","volume":"28","author":"Park S.","year":"2007","unstructured":"Park S.; Park J.Y.; Kim G.H.; Choi J.H.; Kim K.M.; Kim J.B.; Yoo H.W.; Identification of novel ATP7B gene mutations and their functional roles in Korean patients with Wilson disease. Hum Mutat 2007,28(11),1108-1113","journal-title":"Hum Mutat"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<454::AID-HUMU7>3.0.CO;2-J","volume":"15","author":"Okada T.","year":"2000","unstructured":"Okada T.; Shiono Y.; Hayashi H.; Satoh H.; Sawada T.; Suzuki A.; Takeda Y.; Yano M.; Michitaka K.; Onji M.; Mabuchi H.; Mutational analysis of ATP7B and genotype-phenotype correlation in Japanese with Wilson\u2019s disease. Hum Mutat 2000,15(5),454-462","journal-title":"Hum Mutat"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2169\/internalmedicine.49.2931","volume":"49","author":"Tatsumi Y.","year":"2010","unstructured":"Tatsumi Y.; Hattori A.; Hayashi H.; Ikoma J.; Kaito M.; Imoto M.; Wakusawa S.; Yano M.; Hayashi K.; Katano Y.; Goto H.; Okada T.; Kaneko S.; Current state of Wilson disease patients in central Japan. Intern Med 2010,49(9),809-815","journal-title":"Intern Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00439-005-0007-y","volume":"118","author":"Gupta A.","year":"2005","unstructured":"Gupta A.; Aikath D.; Neogi R.; Datta S.; Basu K.; Maity B.; Trivedi R.; Ray J.; Das S.K.; Gangopadhyay P.K.; Ray K.; Molecular pathogenesis of Wilson disease: haplotype analysis, detection of prevalent mutations and genotype-phenotype correlation in Indian patients. Hum Genet 2005,118(1),49-57","journal-title":"Hum Genet"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.parkreldis.2013.09.021","volume":"20","author":"Mukherjee S.","year":"2014","unstructured":"Mukherjee S.; Dutta S.; Majumdar S.; Biswas T.; Jaiswal P.; Sengupta M.; Bhattacharya A.; Gangopadhyay P.K.; Bavdekar A.; Das S.K.; Ray K.; Genetic defects in Indian Wilson disease patients and genotype-phenotype correlation. Parkinsonism Relat Disord 2014,20(1),75-81","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/B978-0-444-63625-6.00003-3","volume":"142","author":"Chang I.J.","year":"2017","unstructured":"Chang I.J.; Hahn S.H.; The genetics of Wilson disease. Handb Clin Neurol 2017,142,19-34","journal-title":"Handb Clin Neurol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/(SICI)1098-1004(199910)14:4<304::AID-HUMU5>3.0.CO;2-W","volume":"14","author":"Curtis D.","year":"1999","unstructured":"Curtis D.; Durkie M.; Balac P.; Sheard D.; Goodeve A.; Peake I.; Quarrell O.; Tanner S.; A study of Wilson disease mutations in Britain. Hum Mutat 1999,14(4),304-311","journal-title":"Hum Mutat"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/cge.12951","volume":"92","author":"Cheng N.","year":"2017","unstructured":"Cheng N.; Wang H.; Wu W.; Yang R.; Liu L.; Han Y.; Guo L.; Hu J.; Xu L.; Zhao J.; Han Y.; Liu Q.; Li K.; Wang X.; Chen W.; Spectrum of ATP7B mutations and genotype-phenotype correlation in large-scale Chinese patients with Wilson Disease. Clin Genet 2017,92(1),69-79","journal-title":"Clin Genet"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/jhg.2012.134","volume":"58","author":"Li K.","year":"2013","unstructured":"Li K.; Zhang W.M.; Lin S.; Wen L.; Wang Z.F.; Xie D.; Wei M.; Qiu Z.Q.; Dai Y.; Lin M.C.; Kung H.F.; Yao F.X.; Mutational analysis of ATP7B in north Chinese patients with Wilson disease. J Hum Genet 2013,58(2),67-72","journal-title":"J Hum Genet"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-230X-10-8","volume":"10","author":"Merle U.","year":"2010","unstructured":"Merle U.; Weiss K.H.; Eisenbach C.; Tuma S.; Ferenci P.; Stremmel W.; Truncating mutations in the Wilson disease gene ATP7B are associated with very low serum ceruloplasmin oxidase activity and an early onset of Wilson disease. BMC Gastroenterol 2010,10,8","journal-title":"BMC Gastroenterol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"16355","DOI":"10.1074\/jbc.M110.198101","volume":"286","author":"Dmitriev O.Y.","year":"2011","unstructured":"Dmitriev O.Y.; Bhattacharjee A.; Nokhrin S.; Uhlemann E.M.; Lutsenko S.; Difference in stability of the N-domain underlies distinct intracellular properties of the E1064A and H1069Q mutants of copper-transporting ATPase ATP7B. J Biol Chem 2011,286(18),16355-16362","journal-title":"J Biol Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"10854","DOI":"10.1073\/pnas.95.18.10854","volume":"95","author":"Payne A.S.","year":"1998","unstructured":"Payne A.S.; Kelly E.J.; Gitlin J.D.; Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation. Proc Natl Acad Sci USA 1998,95(18),10854-10859","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=28","first-page":"309","volume":"83","author":"Wu Z.Y.","year":"2003","unstructured":"Wu Z.Y.; Wang N.; Lin M.T.; Fang L.; Murong S.X.; Genotype-phenotype correlation of patients with wilson disease in Chinese population. Zhonghua Yi Xue Za Zhi 2003,83(4),309-311","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/ajmg.a.61254","volume":"179","author":"Li X.","year":"2019","unstructured":"Li X.; Lu Z.; Lin Y.; Lu X.; Xu Y.; Cheng J.; Shao Y.; Su X.; Liu Z.; Sheng H.; Cai Y.; Li T.; Zhou Z.; Tan J.; Liu H.; Huang Y.; Liu L.; Zeng C.; Clinical features and mutational analysis in 114 young children with Wilson disease from South China. Am J Med Genet A 2019,179(8),1451-1458","journal-title":"Am J Med Genet A"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12264-017-0107-4","volume":"33","author":"Xie J.J.","year":"2017","unstructured":"Xie J.J.; Wu Z.Y.; Wilson\u2019s Disease in China. Neurosci Bull 2017,33(3),323-330","journal-title":"Neurosci Bull"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/brain\/123.3.585","volume":"123","author":"Schiefermeier M.","year":"2000","unstructured":"Schiefermeier M.; Kollegger H.; Madl C.; Polli C.; Oder W.; K&#xFC;hn H.; Berr F.; Ferenci P.; The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson\u2019s disease. Brain 2000,123(Pt 3),585-590","journal-title":"Brain"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jhep.2011.01.030","volume":"55","author":"Gromadzka G.","year":"2011","unstructured":"Gromadzka G.; Rudnicka M.; Chabik G.; Przyby\u0142kowski A.; Cz\u0142onkowska A.; Genetic variability in the methylenetetrahydrofolate reductase gene (MTHFR) affects clinical expression of Wilson\u2019s disease. J Hepatol 2011,55(4),913-919","journal-title":"J Hepatol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev-neuro-071013-014300","volume":"37","author":"Yu J.T.","year":"2014","unstructured":"Yu J.T.; Tan L.; Hardy J.; Apolipoprotein E in Alzheimer\u2019s disease: an update. Annu Rev Neurosci 2014,37,79-100","journal-title":"Annu Rev Neurosci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.parkreldis.2011.12.005","volume":"18","author":"Litwin T.","year":"2012","unstructured":"Litwin T.; Gromadzka G.; Cz\u0142onkowska A.; Apolipoprotein E gene (APOE) genotype in Wilson\u2019s disease: impact on clinical presentation. Parkinsonism Relat Disord 2012,18(4),367-369","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.braindev.2005.01.006","volume":"27","author":"Gu Y.H.","year":"2005","unstructured":"Gu Y.H.; Kodama H.; Du S.L.; Apolipoprotein E genotype analysis in Chinese Han ethnic children with Wilson\u2019s disease, with a concentration on those homozygous for R778L. Brain Dev 2005,27(8),551-553","journal-title":"Brain Dev"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1080\/00365520903225908","volume":"44","author":"Kocabay G.","year":"2009","unstructured":"Kocabay G.; Tutuncu Y.; Yilmaz H.; Demir K.; Impact of apolipoprotein E genotypes on phenotypic expression in Turkish patients with Wilson\u2019s disease. Scand J Gastroenterol 2009,44(10),1270-1271","journal-title":"Scand J Gastroenterol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/liv.13967","volume":"39","author":"Kluska A.","year":"2019","unstructured":"Kluska A.; Kulecka M.; Litwin T.; Dziezyc K.; Balabas A.; Piatkowska M.; Paziewska A.; Dabrowska M.; Mikula M.; Kaminska D.; Wiernicka A.; Socha P.; Czlonkowska A.; Ostrowski J.; Whole-exome sequencing identifies novel pathogenic variants across the ATP7B gene and some modifiers of Wilson\u2019s disease phenotype. Liver Int 2019,39(1),177-186","journal-title":"Liver Int"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.21037\/atm.2019.01.67","volume":"7","author":"Medici V.","year":"2019","unstructured":"Medici V.; LaSalle J.M.; Genetics and epigenetic factors of Wilson disease. Ann Transl Med 2019,7(Suppl. 2),S58","journal-title":"Ann Transl Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1136\/bmj.288.6431.1689-a","volume":"288","year":"1984","unstructured":"Br Med J (Clin Res Ed) Wilson\u2019s disease1984,288(6431),1689","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1046\/j.1469-1809.2001.6550459.x","volume":"65","author":"Olivarez L.","year":"2001","unstructured":"Olivarez L.; Caggana M.; Pass K.A.; Ferguson P.; Brewer G.J.; Estimate of the frequency of Wilson\u2019s disease in the US Caucasian population: a mutation analysis approach. Ann Hum Genet 2001,65(Pt 5),459-463","journal-title":"Ann Hum Genet"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/sj.ejhg.5200566","volume":"8","author":"Olsson C.","year":"2000","unstructured":"Olsson C.; Waldenstr&#xF6;m E.; Westermark K.; Landegre U.; Syv&#xE4;nen A.C.; Determination of the frequencies of ten allelic variants of the Wilson disease gene (ATP7B), in pooled DNA samples. Eur J Hum Genet 2000,8(12),933-938","journal-title":"Eur J Hum Genet"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ncl.2014.09.006","volume":"33","author":"Dusek P.","year":"2015","unstructured":"Dusek P.; Litwin T.; Czlonkowska A.; Wilson disease and other neurodegenerations with metal accumulations. Neurol Clin 2015,33(1),175-204","journal-title":"Neurol Clin"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1096-7192(02)00026-4","volume":"76","author":"Hahn S.H.","year":"2002","unstructured":"Hahn S.H.; Lee S.Y.; Jang Y.J.; Kim S.N.; Shin H.C.; Park S.Y.; Han H.S.; Yu E.S.; Yoo H.W.; Lee J.S.; Chung C.S.; Lee S.Y.; Lee D.H.; Pilot study of mass screening for Wilson\u2019s disease in Korea. Mol Genet Metab 2002,76(2),133-136","journal-title":"Mol Genet Metab"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1023\/A:1005455401076","volume":"22","author":"Ohura T.","year":"1999","unstructured":"Ohura T.; Abukawa D.; Shiraishi H.; Yamaguchi A.; Arashima S.; Hiyamuta S.; Tada K.; Iinuma K.; Pilot study of screening for Wilson disease using dried blood spots obtained from children seen at outpatient clinics. J Inherit Metab Dis 1999,22(1),74-80","journal-title":"J Inherit Metab Dis"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10038-007-0218-2","volume":"53","author":"Mak C.M.","year":"2008","unstructured":"Mak C.M.; Lam C.W.; Tam S.; Lai C.L.; Chan L.Y.; Fan S.T.; Lau Y.L.; Lai J.Y.; Yuen P.; Hui J.; Fu C.C.; Wong K.S.; Mak W.L.; Tze K.; Tong S.F.; Lau A.; Leung N.; Hui A.; Cheung K.M.; Ko C.H.; Chan Y.K.; Ma O.; Chau T.N.; Chiu A.; Chan Y.W.; Mutational analysis of 65 Wilson disease patients in Hong Kong Chinese: identification of 17 novel mutations and its genetic heterogeneity. J Hum Genet 2008,53(1),55-63","journal-title":"J Hum Genet"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1399-0004.2008.01132.x","volume":"75","author":"Park H.D.","year":"2009","unstructured":"Park H.D.; Ki C.S.; Lee S.Y.; Kim J.W.; Carrier frequency of the R778L, A874V, and N1270S mutations in the ATP7B gene in a Korean population. Clin Genet 2009,75(4),405-407","journal-title":"Clin Genet"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1053\/j.gastro.2012.02.035","volume":"142","author":"Ferenci P.","year":"2012","unstructured":"Ferenci P.; Roberts E.A.; Defining Wilson disease phenotypes: from the patient to the bench and back again. Gastroenterology 2012,142(4),692-696","journal-title":"Gastroenterology"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/B978-0-444-63625-6.00005-7","volume":"142","author":"Scheiber I.F.","year":"2017","unstructured":"Scheiber I.F.; Br&#x16F;ha R.; Du\u0161ek P.; Pathogenesis of Wilson disease. Handb Clin Neurol 2017,142,43-55","journal-title":"Handb Clin Neurol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pneurobio.2014.01.002","volume":"116","author":"Scheiber I.F.","year":"2014","unstructured":"Scheiber I.F.; Mercer J.F.; Dringen R.; Metabolism and functions of copper in brain. Prog Neurobiol 2014,116,33-57","journal-title":"Prog Neurobiol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.4103\/0366-6999.159361","volume":"128","author":"Chen C.","year":"2015","unstructured":"Chen C.; Shen B.; Xiao J.J.; Wu R.; Duff Canning S.J.; Wang X.P.; Currently Clinical Views on Genetics of Wilson\u2019s Disease. Chin Med J (Engl) 2015,128(13),1826-1830","journal-title":"Chin Med J (Engl)"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/mnfr.200600107","volume":"51","author":"Schwerdtle T.","year":"2007","unstructured":"Schwerdtle T.; Hamann I.; Jahnke G.; Walter I.; Richter C.; Parsons J.L.; Dianov G.L.; Hartwig A.; Impact of copper on the induction and repair of oxidative DNA damage, poly(ADP-ribosyl)ation and PARP-1 activity. Mol Nutr Food Res 2007,51(2),201-210","journal-title":"Mol Nutr Food Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/B978-0-444-63233-3.00018-X","volume":"147","author":"Lorincz M.T.","year":"2018","unstructured":"Lorincz M.T.; Wilson disease and related copper disorders. Handb Clin Neurol 2018,147,279-292","journal-title":"Handb Clin Neurol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1074\/jbc.M104728200","volume":"277","author":"Lee J.","year":"2002","unstructured":"Lee J.; Pe&#xF1;a M.M.; Nose Y.; Thiele D.J.; Biochemical characterization of the human copper transporter Ctr1. J Biol Chem 2002,277(6),4380-4387","journal-title":"J Biol Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/978-3-319-60189-2_16","volume":"18","author":"Bulcke F.","year":"2017","unstructured":"Bulcke F.; Dringen R.; Scheiber I.F.; Neurotoxicity of Copper. Adv Neurobiol 2017,18,313-343","journal-title":"Adv Neurobiol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.284.5415.805","volume":"284","author":"Rae T.D.","year":"1999","unstructured":"Rae T.D.; Schmidt P.J.; Pufahl R.A.; Culotta V.C.; O\u2019Halloran T.V.; Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science 1999,284(5415),805-808","journal-title":"Science"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"14447","DOI":"10.1074\/jbc.M312693200","volume":"279","author":"Cobine P.A.","year":"2004","unstructured":"Cobine P.A.; Ojeda L.D.; Rigby K.M.; Winge D.R.; Yeast contain a non-proteinaceous pool of copper in the mitochondrial matrix. J Biol Chem 2004,279(14),14447-14455","journal-title":"J Biol Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bbamcr.2008.05.002","volume":"1793","author":"Leary S.C.","year":"2009","unstructured":"Leary S.C.; Winge D.R.; Cobine P.A.; &#x201C;Pulling the plug&#x201D; on cellular copper: the role of mitochondria in copper export. Biochim Biophys Acta 2009,1793(1),146-153","journal-title":"Biochim Biophys Acta"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/iub.1603","volume":"69","author":"Tadini-Buoninsegni F.","year":"2017","unstructured":"Tadini-Buoninsegni F.; Smeazzetto S.; Mechanisms of charge transfer in human copper ATPases ATP7A and ATP7B. IUBMB Life 2017,69(4),218-225","journal-title":"IUBMB Life"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1172\/JCI45401","volume":"121","author":"Zischka H.","year":"2011","unstructured":"Zischka H.; Lichtmannegger J.; Schmitt S.; J&#xE4;gemann N.; Schulz S.; Wartini D.; Jennen L.; Rust C.; Larochette N.; Galluzzi L.; Chajes V.; Bandow N.; Gilles V.S.; DiSpirito A.A.; Esposito I.; Goettlicher M.; Summer K.H.; Kroemer G.; Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease. J Clin Invest 2011,121(4),1508-1518","journal-title":"J Clin Invest"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1006\/abbi.1995.1068","volume":"316","author":"Gunther M.R.","year":"1995","unstructured":"Gunther M.R.; Hanna P.M.; Mason R.P.; Cohen M.S.; Hydroxyl radical formation from cuprous ion and hydrogen peroxide: a spin-trapping study. Arch Biochem Biophys 1995,316(1),515-522","journal-title":"Arch Biochem Biophys"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","volume":"97","author":"Halliwell B.","year":"2006","unstructured":"Halliwell B.; Oxidative stress and neurodegeneration: where are we now? J Neurochem 2006,97(6),1634-1658","journal-title":"J Neurochem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nm1539","volume":"13","author":"Lang P.A.","year":"2007","unstructured":"Lang P.A.; Schenck M.; Nicolay J.P.; Becker J.U.; Kempe D.S.; Lupescu A.; Koka S.; Eisele K.; Klarl B.A.; R&#xFC;bben H.; Schmid K.W.; Mann K.; Hildenbrand S.; Hefter H.; Huber S.M.; Wieder T.; Erhardt A.; H&#xE4;ussinger D.; Gulbins E.; Lang F.; Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 2007,13(2),164-170","journal-title":"Nat Med"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.cbi.2010.06.013","volume":"188","author":"Letelier M.E.","year":"2010","unstructured":"Letelier M.E.; S&#xE1;nchez-Jofr&#xE9; S.; Peredo-Silva L.; Cort&#xE9;s-Troncoso J.; Aracena-Parks P.; Mechanisms underlying iron and copper ions toxicity in biological systems: Pro-oxidant activity and protein-binding effects. Chem Biol Interact 2010,188(1),220-227","journal-title":"Chem Biol Interact"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.chemphyslip.2011.05.006","volume":"164","author":"Yurkova I.L.","year":"2011","unstructured":"Yurkova I.L.; Arnhold J.; Fitzl G.; Huster D.; Fragmentation of mitochondrial cardiolipin by copper ions in the Atp7b-\/- mouse model of Wilson\u2019s disease. Chem Phys Lipids 2011,164(5),393-400","journal-title":"Chem Phys Lipids"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2353\/ajpath.2006.050312","volume":"168","author":"Huster D.","year":"2006","unstructured":"Huster D.; Finegold M.J.; Morgan C.T.; Burkhead J.L.; Nixon R.; Vanderwerf S.M.; Gilliam C.T.; Lutsenko S.; Consequences of copper accumulation in the livers of the Atp7b-\/- (Wilson disease gene) knockout mice. Am J Pathol 2006,168(2),423-434","journal-title":"Am J Pathol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/nyas.12347","volume":"1315","author":"Zischka H.","year":"2014","unstructured":"Zischka H.; Lichtmannegger J.; Pathological mitochondrial copper overload in livers of Wilson\u2019s disease patients and related animal models. Ann N Y Acad Sci 2014,1315,6-15","journal-title":"Ann N Y Acad Sci"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","volume":"56","year":"2012","unstructured":"EASL Clinical Practice Guidelines: Wilson\u2019s disease. J Hepatol European Association for Study of Liver2012,56(3),671-685","journal-title":"J Hepatol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1309\/AJCPDZR4OHDQNG3L","volume":"139","author":"Mounajjed T.","year":"2013","unstructured":"Mounajjed T.; Oxentenko A.S.; Qureshi H.; Smyrk T.C.; Revisiting the topic of histochemically detectable copper in various liver diseases with special focus on venous outflow impairment. Am J Clin Pathol 2013,139(1),79-86","journal-title":"Am J Clin Pathol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1055\/s-0031-1286055","volume":"31","author":"Johncilla M.","year":"2011","unstructured":"Johncilla M.; Mitchell K.A.; Pathology of the liver in copper overload. Semin Liver Dis 2011,31(3),239-244","journal-title":"Semin Liver Dis"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1053\/j.semdp.2019.07.008","volume":"36","author":"Guindi M.","year":"2019","unstructured":"Guindi M.; Wilson disease. Semin Diagn Pathol 2019,36(6),415-422","journal-title":"Semin Diagn Pathol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/B978-0-444-63625-6.00007-0","volume":"142","author":"Pronicki M.","year":"2017","unstructured":"Pronicki M.; Wilson disease - liver pathology. Handb Clin Neurol 2017,142,71-75","journal-title":"Handb Clin Neurol"},{"key":"ref=72","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-230721","volume":"12","author":"Santos B.C.","year":"2019","unstructured":"Santos B.C.; Guedes L.R.; Faria L.C.; Couto C.A.; Wilson\u2019s disease presentation resembling autoimmune hepatitis. BMJ Case Rep 2019,12(10)","journal-title":"BMJ Case Rep"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12011-007-0014-z","volume":"118","author":"Lech T.","year":"2007","unstructured":"Lech T.; Sadlik J.K.; Copper concentration in body tissues and fluids in normal subjects of southern Poland. Biol Trace Elem Res 2007,118(1),10-15","journal-title":"Biol Trace Elem Res"},{"key":"ref=74","first-page":"62","volume":"7","author":"Horoupian D.S.","year":"1988","unstructured":"Horoupian D.S.; Sternlieb I.; Scheinberg I.H.; Neuropathological findings in penicillamine-treated patients with Wilson\u2019s disease. Clin Neuropathol 1988,7(2),62-67","journal-title":"Clin Neuropathol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/B978-0-444-63625-6.00008-2","volume":"142","author":"Poujois A.","year":"2017","unstructured":"Poujois A.; Mikol J.; Woimant F.; Wilson disease: brain pathology. Handb Clin Neurol 2017,142,77-89","journal-title":"Handb Clin Neurol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0946-672X(01)80060-2","volume":"15","author":"Faa G.","year":"2001","unstructured":"Faa G.; Lisci M.; Caria M.P.; Ambu R.; Sciot R.; Nurchi V.M.; Silvagni R.; Diaz A.; Crisponi G.; Brain copper, iron, magnesium, zinc, calcium, sulfur and phosphorus storage in Wilson\u2019s disease. J Trace Elem Med Biol 2001,15(2-3),155-160","journal-title":"J Trace Elem Med Biol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jns.2013.03.021","volume":"329","author":"Litwin T.","year":"2013","unstructured":"Litwin T.; Gromadzka G.; Szpak G.M.; Jab\u0142onka-Salach K.; Bulska E.; Cz\u0142onkowska A.; Brain metal accumulation in Wilson\u2019s disease. J Neurol Sci 2013,329(1-2),55-58","journal-title":"J Neurol Sci"},{"key":"ref=78","first-page":"1273","volume":"8","author":"Hu H.L.","year":"2016","unstructured":"Hu H.L.; Ni X.S.; Duff-Canning S.; Wang X.P.; Oxidative damage of copper chloride overload to the cultured rat astrocytes. Am J Transl Res 2016,8(2),1273-1280","journal-title":"Am J Transl Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neulet.2011.04.058","volume":"498","author":"Scheiber I.F.","year":"2011","unstructured":"Scheiber I.F.; Dringen R.; Copper-treatment increases the cellular GSH content and accelerates GSH export from cultured rat astrocytes. Neurosci Lett 2011,498(1),42-46","journal-title":"Neurosci Lett"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ijdevneu.2011.09.004","volume":"29","author":"Tiffany-Castiglioni E.","year":"2011","unstructured":"Tiffany-Castiglioni E.; Hong S.; Qian Y.; Copper handling by astrocytes: insights into neurodegenerative diseases. Int J Dev Neurosci 2011,29(8),811-818","journal-title":"Int J Dev Neurosci"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12011-013-9665-0","volume":"153","author":"Pal A.","year":"2013","unstructured":"Pal A.; Badyal R.K.; Vasishta R.K.; Attri S.V.; Thapa B.R.; Prasad R.; Biochemical, histological, and memory impairment effects of chronic copper toxicity: a model for non-Wilsonian brain copper toxicosis in Wistar rat. Biol Trace Elem Res 2013,153(1-3),257-268","journal-title":"Biol Trace Elem Res"},{"key":"ref=82","first-page":"73","volume":"39","author":"Bertrand E.","year":"2001","unstructured":"Bertrand E.; Lewandowska E.; Szpak G.M.; Hoogenraad T.; Blaauwgers H.G.; Cz\u0142onkowska A.; Dymecki J.; Neuropathological analysis of pathological forms of astroglia in Wilson\u2019s disease. Folia Neuropathol 2001,39(2),73-79","journal-title":"Folia Neuropathol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12640-013-9453-9","volume":"26","author":"Pal A.","year":"2014","unstructured":"Pal A.; Prasad R.; Recent discoveries on the functions of astrocytes in the copper homeostasis of the brain: a brief update. Neurotox Res 2014,26(1),78-84","journal-title":"Neurotox Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00234-006-0101-4","volume":"48","author":"Sinha S.","year":"2006","unstructured":"Sinha S.; Taly A.B.; Ravishankar S.; Prashanth L.K.; Venugopal K.S.; Arunodaya G.R.; Vasudev M.K.; Swamy H.S.; Wilson\u2019s disease: cranial MRI observations and clinical correlation. Neuroradiology 2006,48(9),613-621","journal-title":"Neuroradiology"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00401-005-1061-1","volume":"110","author":"Mikol J.","year":"2005","unstructured":"Mikol J.; Vital C.; Wassef M.; Chappuis P.; Poupon J.; Lecharpentier M.; Woimant F.; Extensive cortico-subcortical lesions in Wilson\u2019s disease: clinico-pathological study of two cases. Acta Neuropathol 2005,110(5),451-458","journal-title":"Acta Neuropathol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jns.2010.01.007","volume":"291","author":"Prashanth L.K.","year":"2010","unstructured":"Prashanth L.K.; Sinha S.; Taly A.B.; A Mahadevan; Vasudev, M.K.; Shankar, S.K. Spectrum of epilepsy in Wilson\u2019s disease with electroencephalographic, MR imaging and pathological correlates. J Neurol Sci 2010,291(1-2),44-51","journal-title":"J Neurol Sci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1039\/C4MT00242C","volume":"7","author":"Dong Y.","year":"2015","unstructured":"Dong Y.; Shi S.S.; Chen S.; Ni W.; Zhu M.; Wu Z.Y.; The discrepancy between the absence of copper deposition and the presence of neuronal damage in the brain of Atp7b(-\/-) mice. Metallomics 2015,7(2),283-288","journal-title":"Metallomics"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jtemb.2014.05.007","volume":"31","author":"Dusek P.","year":"2015","unstructured":"Dusek P.; Roos P.M.; Litwin T.; Schneider S.A.; Flaten T.P.; Aaseth J.; The neurotoxicity of iron, copper and manganese in Parkinson\u2019s and Wilson\u2019s diseases. J Trace Elem Med Biol 2015,31,193-203","journal-title":"J Trace Elem Med Biol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/nan.12341","volume":"43","author":"Dusek P.","year":"2017","unstructured":"Dusek P.; Bahn E.; Litwin T.; Jab\u0142onka-Salach K.; \u0141uciuk A.; Huelnhagen T.; Madai V.I.; Dieringer M.A.; Bulska E.; Knauth M.; Niendorf T.; Sobesky J.; Paul F.; Schneider S.A.; Czlonkowska A.; Br&#xFC;ck W.; Wegner C.; Wuerfel J.; Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study. Neuropathol Appl Neurobiol 2017,43(6),514-532","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref=90","first-page":"781","volume":"41","author":"Bruehlmeier M.","year":"2000","unstructured":"Bruehlmeier M.; Leenders K.L.; Vontobel P.; Calonder C.; Antonini A.; Weindl A.; Increased cerebral iron uptake in Wilson\u2019s disease: a 52Fe-citrate PET study. J Nucl Med 2000,41(5),781-787","journal-title":"J Nucl Med"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"8981","DOI":"10.3748\/wjg.v21.i29.8981","volume":"21","author":"Abuduxikuer K.","year":"2015","unstructured":"Abuduxikuer K.; Li L.T.; Qiu Y.L.; Wang N.L.; Wang J.S.; Wilson disease with hepatic presentation in an eight-month-old boy. World J Gastroenterol 2015,21(29),8981-8984","journal-title":"World J Gastroenterol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/mds.21985","volume":"23","author":"Cz\u0142onkowska A.","year":"2008","unstructured":"Cz\u0142onkowska A.; Rodo M.; Gromadzka G.; Late onset Wilson\u2019s disease: therapeutic implications. Mov Disord 2008,23(6),896-898","journal-title":"Mov Disord"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/0016-5085(91)80023-3","volume":"100","author":"Schilsky M.L.","year":"1991","unstructured":"Schilsky M.L.; Scheinberg I.H.; Sternlieb I.; Prognosis of Wilsonian chronic active hepatitis. Gastroenterology 1991,100(3),762-767","journal-title":"Gastroenterology"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-444-63625-6.00009-4","volume":"142","author":"Boga S.","year":"2017","unstructured":"Boga S.; Ala A.; Schilsky M.L.; Hepatic features of Wilson disease. Handb Clin Neurol 2017,142,91-99","journal-title":"Handb Clin Neurol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ajh.2830090305","volume":"9","author":"Forman S.J.","year":"1980","unstructured":"Forman S.J.; Kumar K.S.; Redeker A.G.; Hochstein P.; Hemolytic anemia in Wilson disease: clinical findings and biochemical mechanisms. Am J Hematol 1980,9(3),269-275","journal-title":"Am J Hematol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/qjmed\/hct137","volume":"106","author":"Walshe J.M.","year":"2013","unstructured":"Walshe J.M.; The acute haemolytic syndrome in Wilson\u2019s disease--a review of 22 patients. QJM 2013,106(11),1003-1008","journal-title":"QJM"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/BF00716470","volume":"146","author":"Saito T.","year":"1987","unstructured":"Saito T.; Presenting symptoms and natural history of Wilson disease. Eur J Pediatr 1987,146(3),261-265","journal-title":"Eur J Pediatr"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.3748\/wjg.v13.i11.1711","volume":"13","author":"Eisenbach C.","year":"2007","unstructured":"Eisenbach C.; Sieg O.; Stremmel W.; Encke J.; Merle U.; Diagnostic criteria for acute liver failure due to Wilson disease. World J Gastroenterol 2007,13(11),1711-1714","journal-title":"World J Gastroenterol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","volume":"137","author":"Ostapowicz G.","year":"2002","unstructured":"Ostapowicz G.; Fontana R.J.; Schi&#xF8;dt F.V.; Larson A.; Davern T.J.; Han S.H.; McCashland T.M.; Shakil A.O.; Hay J.E.; Hynan L.; Crippin J.S.; Blei A.T.; Samuel G.; Reisch J.; Lee W.M.; Group U.S.A.L.F.S.U.S.; Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med Acute Liver Failure Study Group2002,137(12),947-954","journal-title":"Ann Intern Med"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/MCG.0b013e3181dffaa5","volume":"45","author":"Wong R.J.","year":"2011","unstructured":"Wong R.J.; Gish R.; Schilsky M.; Frenette C.; A clinical assessment of Wilson disease in patients with concurrent liver disease. J Clin Gastroenterol 2011,45(3),267-273","journal-title":"J Clin Gastroenterol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/gut.24.8.767","volume":"24","author":"Wilkinson M.L.","year":"1983","unstructured":"Wilkinson M.L.; Portmann B.; Williams R.; Wilson\u2019s disease and hepatocellular carcinoma: possible protective role of copper. Gut 1983,24(8),767-771","journal-title":"Gut"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/jgh.12716","volume":"30","author":"van Meer S.","year":"2015","unstructured":"van Meer S.; de Man R.A.; van den Berg A.P.; Houwen R.H.; Linn F.H.; van Oijen M.G.; Siersema P.D.; van Erpecum K.J.; No increased risk of hepatocellular carcinoma in cirrhosis due to Wilson disease during long-term follow-up. J Gastroenterol Hepatol 2015,30(3),535-539","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/qjmed\/hcg114","volume":"96","author":"Walshe J.M.","year":"2003","unstructured":"Walshe J.M.; Waldenstr&#xF6;m E.; Sams V.; Nordlinder H.; Westermark K.; Abdominal malignancies in patients with Wilson\u2019s disease. QJM 2003,96(9),657-662","journal-title":"QJM"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1111\/liv.12727","volume":"35","author":"Pfeiffenberger J.","year":"2015","unstructured":"Pfeiffenberger J.; Mogler C.; Gotthardt D.N.; Schulze-Bergkamen H.; Litwin T.; Reuner U.; Hefter H.; Huster D.; Schemmer P.; Cz\u0142onkowska A.; Schirmacher P.; Stremmel W.; Cassiman D.; Weiss K.H.; Hepatobiliary malignancies in Wilson disease. Liver Int 2015,35(5),1615-1622","journal-title":"Liver Int"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/B978-0-444-63625-6.00010-0","volume":"142","author":"Cz\u0142onkowska A.","year":"2017","unstructured":"Cz\u0142onkowska A.; Litwin T.; Chabik G.; Wilson disease: neurologic features. Handb Clin Neurol 2017,142,101-119","journal-title":"Handb Clin Neurol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1749-6632.2009.05109.x","volume":"1184","author":"Lorincz M.T.","year":"2010","unstructured":"Lorincz M.T.; Neurologic Wilson\u2019s disease. Ann N Y Acad Sci 2010,1184,173-187","journal-title":"Ann N Y Acad Sci"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/mds.1118","volume":"16","author":"Svetel M.","year":"2001","unstructured":"Svetel M.; Kozi\u0107 D.; Stefanova E.; Semnic R.; Dragasevic N.; Kostic V.S.; Dystonia in Wilson\u2019s disease. Mov Disord 2001,16(4),719-723","journal-title":"Mov Disord"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000098056","volume":"57","author":"Soltanzadeh A.","year":"2007","unstructured":"Soltanzadeh A.; Soltanzadeh P.; Nafissi S.; Ghorbani A.; Sikaroodi H.; Lotfi J.; Wilson\u2019s disease: a great masquerader. Eur Neurol 2007,57(2),80-85","journal-title":"Eur Neurol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/mds.21170","volume":"21","author":"Machado A.","year":"2006","unstructured":"Machado A.; Chien H.F.; Deguti M.M.; Can&#xE7;ado E.; Azevedo R.S.; Scaff M.; Barbosa E.R.; Neurological manifestations in Wilson\u2019s disease: Report of 119 cases. Mov Disord 2006,21(12),2192-2196","journal-title":"Mov Disord"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1093\/brain\/111.5.1139","volume":"111","author":"Dening T.R.","year":"1988","unstructured":"Dening T.R.; Berrios G.E.; Walshe J.M.; Wilson\u2019s disease and epilepsy. Brain 1988,111(Pt 5),1139-1155","journal-title":"Brain"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.seizure.2010.07.018","volume":"19","author":"Benbir G.","year":"2010","unstructured":"Benbir G.; Gunduz A.; Ertan S.; Ozkara C.; Partial status epilepticus induced by hypocupremia in a patient with Wilson\u2019s disease. Seizure 2010,19(9),602-604","journal-title":"Seizure"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.genhosppsych.2013.08.007","volume":"36","author":"Zimbrean P.C.","year":"2014","unstructured":"Zimbrean P.C.; Schilsky M.L.; Psychiatric aspects of Wilson disease: a review. Gen Hosp Psychiatry 2014,36(1),53-62","journal-title":"Gen Hosp Psychiatry"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jns.2007.09.009","volume":"266","author":"Srinivas K.","year":"2008","unstructured":"Srinivas K.; Sinha S.; Taly A.B.; Prashanth L.K.; Arunodaya G.R.; Janardhana Reddy Y.C.; Khanna S.; Dominant psychiatric manifestations in Wilson\u2019s disease: a diagnostic and therapeutic challenge! J Neurol Sci 2008,266(1-2),104-108","journal-title":"J Neurol Sci"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.neurol.2013.06.002","volume":"169","author":"Wenisch E.","year":"2013","unstructured":"Wenisch E.; De Tassigny A.; Trocello J.M.; Beretti J.; Girardot-Tinant N.; Woimant F.; Cognitive profile in Wilson\u2019s disease: a case series of 31 patients. Rev Neurol (Paris) 2013,169(12),944-949","journal-title":"Rev Neurol (Paris)"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/mds.10195","volume":"17","author":"Seni&#xF3;w J.","year":"2002","unstructured":"Seni&#xF3;w J.; Bak T.; Gajda J.; Poniatowska R.; Czlonkowska A.; Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson\u2019s disease. Mov Disord 2002,17(5),1077-1083","journal-title":"Mov Disord"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1037\/neu0000103","volume":"29","author":"Iwa\u0144ski S.","year":"2015","unstructured":"Iwa\u0144ski S.; Seni&#xF3;w J.; Le&#x15B;niak M.; Litwin T.; Cz\u0142onkowska A.; Diverse attention deficits in patients with neurologically symptomatic and asymptomatic Wilson\u2019s disease. Neuropsychology 2015,29(1),25-30","journal-title":"Neuropsychology"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/ICO.0000000000001126","volume":"36","author":"Sridhar M.S.","year":"2017","unstructured":"Sridhar M.S.; Advantages of Anterior Segment Optical Coherence Tomography Evaluation of the Kayser-Fleischer Ring in Wilson Disease. Cornea 2017,36(3),343-346","journal-title":"Cornea"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"e757","DOI":"10.1111\/aos.14009","volume":"97","author":"Broniek-Kowalik K.","year":"2019","unstructured":"Broniek-Kowalik K.; Dzie&#x17C;yc K.; Litwin T.; Cz\u0142onkowska A.; Szaflik J.P.; Anterior segment optical coherence tomography (AS-OCT) as a new method of detecting copper deposits forming the Kayser-Fleischer ring in patients with Wilson disease. Acta Ophthalmol 2019,97(5),e757-e760","journal-title":"Acta Ophthalmol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11011-015-9776-8","volume":"31","author":"Langwi\u0144ska-Wo&#x15B;ko E.","year":"2016","unstructured":"Langwi\u0144ska-Wo&#x15B;ko E.; Litwin T.; Szulborski K.; Cz\u0142onkowska A.; Optical coherence tomography and electrophysiology of retinal and visual pathways in Wilson\u2019s disease. Metab Brain Dis 2016,31(2),405-415","journal-title":"Metab Brain Dis"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s13760-017-0788-5","volume":"117","author":"Langwi\u0144ska-Wo&#x15B;ko E.","year":"2017","unstructured":"Langwi\u0144ska-Wo&#x15B;ko E.; Litwin T.; Dzie&#x17C;yc K.; Karlinski M.; Cz\u0142onkowska A.; Optical coherence tomography as a marker of neurodegeneration in patients with Wilson\u2019s disease. Acta Neurol Belg 2017,117(4),867-871","journal-title":"Acta Neurol Belg"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/B978-0-444-63625-6.00013-6","volume":"142","author":"Dzie&#x17C;yc K.","year":"2017","unstructured":"Dzie&#x17C;yc K.; Litwin T.; Cz\u0142onkowska A.; Other organ involvement and clinical aspects of Wilson disease. Handb Clin Neurol 2017,142,157-169","journal-title":"Handb Clin Neurol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"857","DOI":"10.5114\/aoms.2017.69728","volume":"15","author":"Buksi\u0144ska-Lisik M.","year":"2019","unstructured":"Buksi\u0144ska-Lisik M.; Litwin T.; Pasierski T.; Cz\u0142onkowska A.; Cardiac assessment in Wilson\u2019s disease patients based on electrocardiography and echocardiography examination. Arch Med Sci 2019,15(4),857-864","journal-title":"Arch Med Sci"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1016\/j.jacc.2018.08.2197","volume":"72","author":"Quick S.","year":"2018","unstructured":"Quick S.; Weidauer M.; Heidrich F.M.; Sveric K.; Reichmann H.; Ibrahim K.; Strasser R.H.; Linke A.; Speiser U.; Reuner U.; Cardiac Manifestation of Wilson\u2019s Disease. J Am Coll Cardiol 2018,72(22),2808-2809","journal-title":"J Am Coll Cardiol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1034\/j.1600-0676.2003.00824.x","volume":"23","author":"Ferenci P.","year":"2003","unstructured":"Ferenci P.; Caca K.; Loudianos G.; Mieli-Vergani G.; Tanner S.; Sternlieb I.; Schilsky M.; Cox D.; Berr F.; Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003,23(3),139-142","journal-title":"Liver Int"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1196\/annals.1306.024","volume":"1012","author":"Xu X.","year":"2004","unstructured":"Xu X.; Pin S.; Gathinji M.; Fuchs R.; Harris Z.L.; Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Ann N Y Acad Sci 2004,1012,299-305","journal-title":"Ann N Y Acad Sci"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/ejhg.2009.187","volume":"18","author":"T&#xFC;mer Z.","year":"2010","unstructured":"T&#xFC;mer Z.; M&#xF8;ller L.B.; Menkes disease. Eur J Hum Genet 2010,18(5),511-518","journal-title":"Eur J Hum Genet"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s12041-010-0065-3","volume":"89","author":"Gromadzka G.","year":"2010","unstructured":"Gromadzka G.; Chabik G.; Mendel T.; Wierzchowska A.; Rudnicka M.; Czlonkowska A.; Middle-aged heterozygous carriers of Wilson\u2019s disease do not present with significant phenotypic deviations related to copper metabolism. J Genet 2010,89(4),463-467","journal-title":"J Genet"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.clinre.2018.03.007","volume":"42","author":"Poujois A.","year":"2018","unstructured":"Poujois A.; Woimant F.; Wilson\u2019s disease: A 2017 update. Clin Res Hepatol Gastroenterol 2018,42(6),512-520","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00216-009-2809-6","volume":"394","author":"El Balkhi S.","year":"2009","unstructured":"El Balkhi S.; Poupon J.; Trocello J.M.; Leyendecker A.; Massicot F.; Galliot-Guilley M.; Woimant F.; Determination of ultrafiltrable and exchangeable copper in plasma: stability and reference values in healthy subjects. Anal Bioanal Chem 2009,394(5),1477-1484","journal-title":"Anal Bioanal Chem"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.cca.2011.08.019","volume":"412","author":"El Balkhi S.","year":"2011","unstructured":"El Balkhi S.; Trocello J.M.; Poupon J.; Chappuis P.; Massicot F.; Girardot-Tinant N.; Woimant F.; Relative exchangeable copper: a new highly sensitive and highly specific biomarker for Wilson\u2019s disease diagnosis. Clin Chim Acta 2011,412(23-24),2254-2260","journal-title":"Clin Chim Acta"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/hep.23910","volume":"52","author":"Nicastro E.","year":"2010","unstructured":"Nicastro E.; Ranucci G.; Vajro P.; Vegnente A.; Iorio R.; Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. Hepatology 2010,52(6),1948-1956","journal-title":"Hepatology"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/hep.1840150410","volume":"15","author":"Martins da Costa C.","year":"1992","unstructured":"Martins da Costa C.; Baldwin D.; Portmann B.; Lolin Y.; Mowat A.P.; Mieli-Vergani G.; Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson\u2019s disease. Hepatology 1992,15(4),609-615","journal-title":"Hepatology"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S1542-3565(05)00181-3","volume":"3","author":"Ferenci P.","year":"2005","unstructured":"Ferenci P.; Steindl-Munda P.; Vogel W.; Jessner W.; Gschwantler M.; Stauber R.; Datz C.; Hackl F.; Wrba F.; Bauer P.; Lorenz O.; Diagnostic value of quantitative hepatic copper determination in patients with Wilson\u2019s Disease. Clin Gastroenterol Hepatol 2005,3(8),811-818","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2214\/ajr.167.6.8956601","volume":"167","author":"King A.D.","year":"1996","unstructured":"King A.D.; Walshe J.M.; Kendall B.E.; Chinn R.J.; Paley M.N.; Wilkinson I.D.; Halligan S.; Hall-Craggs M.A.; Cranial MR imaging in Wilson\u2019s disease. AJR Am J Roentgenol 1996,167(6),1579-1584","journal-title":"AJR Am J Roentgenol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1046\/j.1468-1331.2003.00661.x","volume":"10","author":"Kozi\u0107 D.","year":"2003","unstructured":"Kozi\u0107 D.; Svetel M.; Petrovi\u0107 B.; Dragasevi\u0107 N.; Semnic R.; Kosti\u0107 V.S.; MR imaging of the brain in patients with hepatic form of Wilson\u2019s disease. Eur J Neurol 2003,10(5),587-592","journal-title":"Eur J Neurol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"393","DOI":"10.5114\/ninp.2013.36763","volume":"47","author":"Litwin T.","year":"2013","unstructured":"Litwin T.; Dzie&#x17C;yc K.; Poniatowska R.; Cz\u0142onkowska A.; Effect of liver transplantation on brain magnetic resonance imaging pathology in Wilson disease: a case report. Neurol Neurochir Pol 2013,47(4),393-397","journal-title":"Neurol Neurochir Pol"},{"key":"ref=137","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28018","author":"Dusek P.","year":"2020","unstructured":"Dusek P.; Smolinski L.; Redzia-Ogrodnik B.; Golebiowski M.; Skowronska M.; Poujois A.; Laurencin C.; Jastrzebska-Kurkowska I.; Litwin T.; Cz\u0142onkowska A.; Semiquantitative scale for assessing brain MRI Abnormalities in Wilson Disease: A Validation Study. Mov Disord 2020","journal-title":"Mov Disord"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"542","DOI":"10.5114\/ninp.2013.39071","volume":"47","author":"Skowro\u0144ska M.","year":"2013","unstructured":"Skowro\u0144ska M.; Litwin T.; Dzie&#x17C;yc K.; Wierzchowska A.; Cz\u0142onkowska A.; Does brain degeneration in Wilson disease involve not only copper but also iron accumulation? Neurol Neurochir Pol 2013,47(6),542-546","journal-title":"Neurol Neurochir Pol"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/pr.2013.239","volume":"75","author":"Bai X.","year":"2014","unstructured":"Bai X.; Wang G.; Wu L.; Liu Y.; Cui L.; Shi H.; Guo L.; Deep-gray nuclei susceptibility-weighted imaging filtered phase shift in patients with Wilson\u2019s disease. Pediatr Res 2014,75(3),436-442","journal-title":"Pediatr Res"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/jmri.25693","volume":"46","author":"Wang Y.","year":"2017","unstructured":"Wang Y.; Spincemaille P.; Liu Z.; Dimov A.; Deh K.; Li J.; Zhang Y.; Yao Y.; Gillen K.M.; Wilman A.H.; Gupta A.; Tsiouris A.J.; Kovanlikaya I.; Chiang G.C.; Weinsaft J.W.; Tanenbaum L.; Chen W.; Zhu W.; Chang S.; Lou M.; Kopell B.H.; Kaplitt M.G.; Devos D.; Hirai T.; Huang X.; Korogi Y.; Shtilbans A.; Jahng G.H.; Pelletier D.; Gauthier S.A.; Pitt D.; Bush A.I.; Brittenham G.M.; Prince M.R.; Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care. J Magn Reson Imaging 2017,46(4),951-971","journal-title":"J Magn Reson Imaging"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/RLI.0000000000000010","volume":"49","author":"Fritzsch D.","year":"2014","unstructured":"Fritzsch D.; Reiss-Zimmermann M.; Trampel R.; Turner R.; Hoffmann K.T.; Sch&#xE4;fer A.; Seven-tesla magnetic resonance imaging in Wilson disease using quantitative susceptibility mapping for measurement of copper accumulation. Invest Radiol 2014,49(5),299-306","journal-title":"Invest Radiol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1177\/0284185118759821","volume":"59","author":"Saracoglu S.","year":"2018","unstructured":"Saracoglu S.; Gumus K.; Doganay S.; Koc G.; Kacar Bayram A.; Arslan D.; Gumus H.; Brain susceptibility changes in neurologically asymptomatic pediatric patients with Wilson\u2019s disease: evaluation with quantitative susceptibility mapping. Acta Radiol 2018,59(11),1380-1385","journal-title":"Acta Radiol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2463\/mrms.mp.2016-0145","volume":"17","author":"Doganay S.","year":"2018","unstructured":"Doganay S.; Gumus K.; Koc G.; Bayram A.K.; Dogan M.S.; Arslan D.; Gumus H.; Gorkem S.B.; Ciraci S.; Serin H.I.; Coskun A.; Magnetic susceptibility changes in the basal ganglia and brain stem of patients with Wilson\u2019s Disease: evaluation with quantitative susceptibility mapping. Magn Reson Med Sci 2018,17(1),73-79","journal-title":"Magn Reson Med Sci"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/mds.25492","volume":"28","author":"Mart&#xED;nez-Fern&#xE1;ndez R.","year":"2013","unstructured":"Mart&#xED;nez-Fern&#xE1;ndez R.; Caballol N.; G&#xF3;mez-Choco M.; MRI and transcranial sonography findings in Wilson\u2019s disease. Mov Disord 2013,28(6),740","journal-title":"Mov Disord"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/mds.22163","volume":"23","author":"Tarnacka B.","year":"2008","unstructured":"Tarnacka B.; Szeszkowski W.; Golebiowski M.; Czlonkowska A.; MR spectroscopy in monitoring the treatment of Wilson\u2019s disease patients. Mov Disord 2008,23(11),1560-1566","journal-title":"Mov Disord"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/B978-0-444-63625-6.00014-8","volume":"142","author":"Ferenci P.","year":"2017","unstructured":"Ferenci P.; Diagnosis of Wilson disease. Handb Clin Neurol 2017,142,171-180","journal-title":"Handb Clin Neurol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1002\/mds.26057","volume":"29","author":"Dzie&#x17C;yc K.","year":"2014","unstructured":"Dzie&#x17C;yc K.; Litwin T.; Chabik G.; Gramza K.; Cz\u0142onkowska A.; Families with Wilson\u2019s disease in subsequent generations: clinical and genetic analysis. Mov Disord 2014,29(14),1828-1832","journal-title":"Mov Disord"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/ene.12320","volume":"21","author":"Dzie&#x17C;yc K.","year":"2014","unstructured":"Dzie&#x17C;yc K.; Karli\u0144ski M.; Litwin T.; Cz\u0142onkowska A.; Compliant treatment with anti-copper agents prevents clinically overt Wilson\u2019s disease in pre-symptomatic patients. Eur J Neurol 2014,21(2),332-337","journal-title":"Eur J Neurol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1002\/hep.22261","volume":"47","author":"Roberts E.A.","year":"2008","unstructured":"Roberts E.A.; Schilsky M.L.; American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology 2008,47(6),2089-2111","journal-title":"Hepatology"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0300-483X(86)90089-2","volume":"42","author":"Heilmaier H.E.","year":"1986","unstructured":"Heilmaier H.E.; Jiang J.L.; Greim H.; Schramel P.; Summer K.H.; D-penicillamine induces rat hepatic metallothionein. Toxicology 1986,42(1),23-31","journal-title":"Toxicology"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/B978-0-444-63625-6.00015-X","volume":"142","author":"Cz\u0142onkowska A.","year":"2017","unstructured":"Cz\u0142onkowska A.; Litwin T.; Wilson disease - currently used anticopper therapy. Handb Clin Neurol 2017,142,181-191","journal-title":"Handb Clin Neurol"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/gut.2005.087262","volume":"56","author":"Merle U.","year":"2007","unstructured":"Merle U.; Schaefer M.; Ferenci P.; Stremmel W.; Clinical presentation, diagnosis and long-term outcome of Wilson\u2019s disease: a cohort study. Gut 2007,56(1),115-120","journal-title":"Gut"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1053\/j.gastro.2010.12.034]","volume":"140","author":"Weiss K.H.","year":"2011","unstructured":"Weiss K.H.; Gotthardt D.N.; Klemm D.; Merle U.; Ferenci-Foerster D.; Schaefer M.; Ferenci P.; Stremmel W.; Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology 2011,140(4),1189-1198.e1181","journal-title":"Gastroenterology"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/archneur.1987.00520170020016","volume":"44","author":"Brewer G.J.","year":"1987","unstructured":"Brewer G.J.; Terry C.A.; Aisen A.M.; Hill G.M.; Worsening of neurologic syndrome in patients with Wilson\u2019s disease with initial penicillamine therapy. Arch Neurol 1987,44(5),490-493","journal-title":"Arch Neurol"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(07)60196-2","volume":"369","author":"Ala A.","year":"2007","unstructured":"Ala A.; Walker A.P.; Ashkan K.; Dooley J.S.; Schilsky M.L.; Wilson\u2019s disease. Lancet 2007,369(9559),397-408","journal-title":"Lancet"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/01.mcg.0000225670.91722.59","volume":"40","author":"Medici V.","year":"2006","unstructured":"Medici V.; Trevisan C.P.; D\u2019Inc&#xE0; R.; Barollo M.; Zancan L.; Fagiuoli S.; Martines D.; Irato P.; Sturniolo G.C.; Diagnosis and management of Wilson\u2019s disease: results of a single center experience. J Clin Gastroenterol 2006,40(10),936-941","journal-title":"J Clin Gastroenterol"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0140-6736(82)92201-2","volume":"1","author":"Walshe J.M.","year":"1982","unstructured":"Walshe J.M.; Treatment of Wilson\u2019s disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1982,1(8273),643-647","journal-title":"Lancet"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0022-3476(96)70412-2","volume":"128","author":"Santos Silva E.E.","year":"1996","unstructured":"Santos Silva E.E.; Sarles J.; Buts J.P.; Sokal E.M.; Successful medical treatment of severely decompensated Wilson disease. J Pediatr 1996,128(2),285-287","journal-title":"J Pediatr"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/archneur.63.4.521","volume":"63","author":"Brewer G.J.","year":"2006","unstructured":"Brewer G.J.; Askari F.; Lorincz M.T.; Carlson M.; Schilsky M.; Kluin K.J.; Hedera P.; Moretti P.; Fink J.K.; Tankanow R.; Dick R.B.; Sitterly J.; Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol 2006,63(4),521-527","journal-title":"Arch Neurol"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.cgh.2013.03.012","volume":"11","author":"Weiss K.H.","year":"2013","unstructured":"Weiss K.H.; Thurik F.; Gotthardt D.N.; Schafer M.; Teufel U.; Wiegand F.; Merle U.; Ferenci-Foerster D.; Maieron A.; Stauber R.; Zoller H.; Schmidt H.H.; Reuner U.; Hefter H.; Trocello J.M.; Houwen R.H.; Ferenci P.; Stremmel W.; Consortium E.; Efficacy and safety of oral chelators in treatment of patients with Wilson Dsease. Clin Gastroenterol Hepatol 2013,11(8),1028-1035","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/archneur.1994.00540180023009","volume":"51","author":"Brewer G.J.","year":"1994","unstructured":"Brewer G.J.; Dick R.D.; Johnson V.; Wang Y.; Yuzbasiyan-Gurkan V.; Kluin K.; Fink J.K.; Aisen A.; Treatment of Wilson\u2019s disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients. Arch Neurol 1994,51(6),545-554","journal-title":"Arch Neurol"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archneur.60.3.379","volume":"60","author":"Brewer G.J.","year":"2003","unstructured":"Brewer G.J.; Hedera P.; Kluin K.J.; Carlson M.; Askari F.; Dick R.B.; Sitterly J.; Fink J.K.; Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 2003,60(3),379-385","journal-title":"Arch Neurol"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S2468-1253(17)30293-5","volume":"2","author":"Weiss K.H.","year":"2017","unstructured":"Weiss K.H.; Askari F.K.; Czlonkowska A.; Ferenci P.; Bronstein J.M.; Bega D.; Ala A.; Nicholl D.; Flint S.; Olsson L.; Plitz T.; Bjartmar C.; Schilsky M.L.; Bis-choline tetrathiomolybdate in patients with Wilson\u2019s disease: an open-label, multicentre, phase 2 study. Lancet Gastroenterol Hepatol 2017,2(12),869-876","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1172\/JCI114333","volume":"84","author":"Schilsky M.L.","year":"1989","unstructured":"Schilsky M.L.; Blank R.R.; Czaja M.J.; Zern M.A.; Scheinberg I.H.; Stockert R.J.; Sternlieb I.; Hepatocellular copper toxicity and its attenuation by zinc. J Clin Invest 1989,84(5),1562-1568","journal-title":"J Clin Invest"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.braindev.2005.08.008","volume":"28","author":"Hoogenraad T.U.","year":"2006","unstructured":"Hoogenraad T.U.; Paradigm shift in treatment of Wilson\u2019s disease: zinc therapy now treatment of choice. Brain Dev 2006,28(3),141-146","journal-title":"Brain Dev"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF00868525","volume":"243","author":"Czlonkowska A.","year":"1996","unstructured":"Czlonkowska A.; Gajda J.; Rodo M.; Effects of long-term treatment in Wilson\u2019s disease with D-penicillamine and zinc sulphate. J Neurol 1996,243(3),269-273","journal-title":"J Neurol"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/ene.12348","volume":"21","author":"Cz\u0142onkowska A.","year":"2014","unstructured":"Cz\u0142onkowska A.; Litwin T.; Karli\u0144ski M.; Dziezyc K.; Chabik G.; Czerska M.; D-penicillamine versus zinc sulfate as first-line therapy for Wilson\u2019s disease. Eur J Neurol 2014,21(4),599-606","journal-title":"Eur J Neurol"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10072-018-3557-1","volume":"40","author":"Zaino D.","year":"2019","unstructured":"Zaino D.; Chiarotti I.; Battisti C.; Salvatore S.; Federico A.; Cerase A.; Six-year clinical and MRI quantitative susceptibility mapping (QSM) follow-up in neurological Wilson\u2019s disease under zinc therapy: a case report. Neurol Sci 2019,40(1),199-201","journal-title":"Neurol Sci"},{"key":"ref=169","first-page":"694","volume":"110","author":"Ren M.","year":"1997","unstructured":"Ren M.; Yang R.; Clinical curative effects of dimercaptosuccinic acid on hepatolenticular degeneration and the impact of DMSA on biliary trace elements. Chin Med J (Engl) 1997,110(9),694-697","journal-title":"Chin Med J (Engl)"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"322","DOI":"10.2174\/1570159X14666151130222427","volume":"14","author":"Li W.J.","year":"2016","unstructured":"Li W.J.; Chen C.; You Z.F.; Yang R.M.; Wang X.P.; Current Drug Managements of Wilson\u2019s Disease: From West to East. Curr Neuropharmacol 2016,14(4),322-325","journal-title":"Curr Neuropharmacol"},{"key":"ref=171","first-page":"149","volume":"18","author":"Wang X.P.","year":"2003","unstructured":"Wang X.P.; Yang R.M.; Ren M.S.; Sun B.M.; Anticopper efficacy of captopril and sodium dimercaptosulphonate in patients with Wilson\u2019s disease. Funct Neurol 2003,18(3),149-153","journal-title":"Funct Neurol"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s11596-013-1190-z","volume":"33","author":"Xu S.Q.","year":"2013","unstructured":"Xu S.Q.; Li X.F.; Zhu H.Y.; Liu Y.; Fang F.; Chen L.; Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson\u2019s disease. J Huazhong Univ Sci Technolog Med Sci 2013,33(5),743-747","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000321648","volume":"64","author":"Wang X.P.","year":"2010","unstructured":"Wang X.P.; Zhang W.F.; Huang H.Y.; Preter M.; Neurology in the People\u2019s Republic of China--an update. Eur Neurol 2010,64(6),320-324","journal-title":"Eur Neurol"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ctim.2011.12.004","volume":"20","author":"Wang Y.","year":"2012","unstructured":"Wang Y.; Xie C.L.; Fu D.L.; Lu L.; Lin Y.; Dong Q.Q.; Wang X.T.; Zheng G.Q.; Clinical efficacy and safety of Chinese herbal medicine for Wilson\u2019s disease: a systematic review of 9 randomized controlled trials. Complement Ther Med 2012,20(3),143-154","journal-title":"Complement Ther Med"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11655-012-1089-8","volume":"19","author":"Li W.J.","year":"2013","unstructured":"Li W.J.; Wang J.F.; Wang X.P.; Wilson\u2019s disease: update on integrated Chinese and Western medicine. Chin J Integr Med 2013,19(3),233-240","journal-title":"Chin J Integr Med"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jns.2015.06.010","volume":"355","author":"Litwin T.","year":"2015","unstructured":"Litwin T.; Dzie&#x17C;yc K.; Karli\u0144ski M.; Chabik G.; Czepiel W.; Cz\u0142onkowska A.; Early neurological worsening in patients with Wilson\u2019s disease. J Neurol Sci 2015,355(1-2),162-167","journal-title":"J Neurol Sci"},{"key":"ref=177","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015917]","volume":"98","author":"Li L.Y.","year":"2019","unstructured":"Li L.Y.; Zhu X.Q.; Tao W.W.; Yang W.M.; Chen H.Z.; Wang Y.; Acute onset neurological symptoms in Wilson disease after traumatic, surgical or emotional events: A cross-sectional study. Medicine (Baltimore) 2019,98(26)","journal-title":"Medicine (Baltimore)"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12883-019-1502-4","volume":"19","author":"Mase\u0142bas W.","year":"2019","unstructured":"Mase\u0142bas W.; Cz\u0142onkowska A.; Litwin T.; Niewada M.; Persistence with treatment for Wilson disease: a retrospective study. BMC Neurol 2019,19(1),278","journal-title":"BMC Neurol"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/nyas.12454","volume":"1315","author":"Schilsky M.L.","year":"2014","unstructured":"Schilsky M.L.; Liver transplantation for Wilson\u2019s disease. Ann N Y Acad Sci 2014,1315,45-49","journal-title":"Ann N Y Acad Sci"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/lt.20352","volume":"11","author":"Dhawan A.","year":"2005","unstructured":"Dhawan A.; Taylor R.M.; Cheeseman P.; De Silva P.; Katsiyiannakis L.; Mieli-Vergani G.; Wilson\u2019s disease in children: 37-year experience and revised King\u2019s score for liver transplantation. Liver Transpl 2005,11(4),441-448","journal-title":"Liver Transpl"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/hep.1840190307","volume":"19","author":"Schilsky M.L.","year":"1994","unstructured":"Schilsky M.L.; Scheinberg I.H.; Sternlieb I.; Liver transplantation for Wilson\u2019s disease: indications and outcome. Hepatology 1994,19(3),583-587","journal-title":"Hepatology"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0168-8278(95)80194-4","volume":"23","author":"Bellary S.","year":"1995","unstructured":"Bellary S.; Hassanein T.; Van Thiel D.H.; Liver transplantation for Wilson\u2019s disease. J Hepatol 1995,23(4),373-381","journal-title":"J Hepatol"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.transproceed.2019.01.017","volume":"51","author":"Garoufalia Z.","year":"2019","unstructured":"Garoufalia Z.; Prodromidou A.; Machairas N.; Kostakis I.D.; Stamopoulos P.; Zavras N.; Fouzas I.; Sotiropoulos G.C.; Liver Transplantation for Wilson\u2019s Disease in Non-adult Patients: A Systematic Review. Transplant Proc 2019,51(2),443-445","journal-title":"Transplant Proc"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/mds.21913","volume":"23","author":"Litwin T.","year":"2008","unstructured":"Litwin T.; Gromadzka G.; Cz\u0142onkowska A.; Neurological presentation of Wilson\u2019s disease in a patient after liver transplantation. Mov Disord 2008,23(5),743-746","journal-title":"Mov Disord"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/B978-0-444-63625-6.00016-1","volume":"142","author":"Ahmad A.","year":"2017","unstructured":"Ahmad A.; Torrazza-Perez E.; Schilsky M.L.; Liver transplantation for Wilson disease. Handb Clin Neurol 2017,142,193-204","journal-title":"Handb Clin Neurol"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/B978-0-444-63625-6.00017-3","volume":"142","author":"Pfeiffenberger J.","year":"2017","unstructured":"Pfeiffenberger J.; Weiss K.H.; Stremmel W.; Wilson disease: symptomatic liver therapy. Handb Clin Neurol 2017,142,205-209","journal-title":"Handb Clin Neurol"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/B978-0-444-63625-6.00018-5","volume":"142","author":"Litwin T.","year":"2017","unstructured":"Litwin T.; Du\u0161ek P.; Cz\u0142onkowska A.; Symptomatic treatment of neurologic symptoms in Wilson disease. Handb Clin Neurol 2017,142,211-223","journal-title":"Handb Clin Neurol"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.21037\/atm.2019.02.43","volume":"7","author":"Dusek P.","year":"2019","unstructured":"Dusek P.; Litwin T.; Cz\u0142onkowska A.; Neurologic impairment in Wilson disease. Ann Transl Med 2019,7(Suppl. 2),S64","journal-title":"Ann Transl Med"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/nyas.12372","volume":"1315","author":"Hedera P.","year":"2014","unstructured":"Hedera P.; Treatment of Wilson\u2019s disease motor complications with deep brain stimulation. Ann N Y Acad Sci 2014,1315,16-23","journal-title":"Ann N Y Acad Sci"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"502","DOI":"10.5114\/ninp.2013.38230","volume":"47","author":"Litwin T.","year":"2013","unstructured":"Litwin T.; Chabik G.; Cz\u0142onkowska A.; Acute focal dystonia induced by a tricyclic antidepressant in a patient with Wilson disease: a case report. Neurol Neurochir Pol 2013,47(5),502-506","journal-title":"Neurol Neurochir Pol"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/2045125318759461","volume":"8","author":"Litwin T.","year":"2018","unstructured":"Litwin T.; Dusek P.; Szafra\u0144ski T.; Dzie&#x17C;yc K.; Cz\u0142onkowska A.; Rybakowski J.K.; Psychiatric manifestations in Wilson\u2019s disease: possibilities and difficulties for treatment. Ther Adv Psychopharmacol 2018,8(7),199-211","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jhep.2015.09.014","volume":"64","author":"Murillo O.","year":"2016","unstructured":"Murillo O.; Luqui D.M.; Gazquez C.; Martinez-Espartosa D.; Navarro-Blasco I.; Monreal J.I.; Guembe L.; Moreno-Cerme&#xF1;o A.; Corrales F.J.; Prieto J.; Hernandez-Alcoceba R.; Gonzalez-Aseguinolaza G.; Long-term metabolic correction of Wilson\u2019s disease in a murine model by gene therapy. J Hepatol 2016,64(2),419-426","journal-title":"J Hepatol"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/nyas.12450","volume":"1315","author":"Gupta S.","year":"2014","unstructured":"Gupta S.; Cell therapy to remove excess copper in Wilson\u2019s disease. Ann N Y Acad Sci 2014,1315,70-80","journal-title":"Ann N Y Acad Sci"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/181503","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/181503\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/181503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T06:56:51Z","timestamp":1645945011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/181503\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":193,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x18666200429233517","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-03-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}